摘要
1文献来源
Low-dose Interleukin-2 immunotherapy does not improve outcome of patients age 60 years and older with acute myeloid leukemia in first complete remission: Cancer and Leukemia Group B Study 9720. [J]. J Clin Oncol, 2008,12(26):4934-4939.
出处
《循证医学》
CSCD
2009年第5期274-276,共3页
The Journal of Evidence-Based Medicine
关键词
急性髓性白血病
老年患者
白介素2
acute myeloid leukemia
elderly patients
Interleukin-2 (IL-2)